Accéder au contenu
Merck

Dexamethasone inhibits endotoxin-induced coagulopathy in human lungs.

Journal of thrombosis and haemostasis : JTH (2016-10-25)
J Bartko, C Schoergenhofer, M Schwameis, N Buchtele, J Wojta, G Schabbauer, L Stiebellehner, B Jilma
RÉSUMÉ

Essentials Glucocorticoids are associated with an increased risk of thrombosis. Healthy volunteers received dexamethasone or placebo in an endotoxin lung instillation model. Dexamethasone suppressed thrombin generation in bronchoalveolar lavage. Glucocorticoids inhibit endotoxin induced pulmonary coagulopathy. Background Activation of local and systemic coagulation is a common finding in patients with pneumonia. There is evidence that glucocorticoids have procoagulant activity in the circulation, particularly in the context of inflammation. The effects of glucocorticoids on local pulmonary coagulation have not yet been investigated. Objective To use a human model of lung inflammation based on the local instillation of endotoxin in order to investigate whether glucocorticoids alter pulmonary coagulation. Methods Twenty-four healthy volunteers were randomized to receive either dexamethasone or placebo in a double-blind trial. Endotoxin was instilled via bronchoscope into right or left lung segments, followed by saline into the contralateral site. Six hours later, a bilateral bronchoalveolar lavage (BAL) was performed and coagulation parameters were measured. Results Endotoxin induced activation of coagulation in the bronchoalveolar compartment: the level of prothrombin fragment 1 + 2 (F

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Human F3 / Tissue Factor ELISA Kit